View in EDS HTML Full Text PDF Full Text

RBM39 shapes innate immunity by controlling the expression of key factors of the interferon response.

Saved in:
Bibliographic Details
Title: RBM39 shapes innate immunity by controlling the expression of key factors of the interferon response.
Authors: Li TF; Department of Infectious Diseases, Molecular Virology, Section Virus-Host-Interactions, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany., Rothhaar P; Department of Infectious Diseases, Molecular Virology, Section Virus-Host-Interactions, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany., Lang A; Department of Infectious Diseases, Molecular Virology, Section Virus-Host-Interactions, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany., Grünvogel O; Department of Infectious Diseases, Molecular Virology, Section Virus-Host-Interactions, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany., Colasanti O; Department of Infectious Diseases, Molecular Virology, Section Virus-Host-Interactions, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany., Ugarte SMO; Department of Infectious Diseases, Molecular Virology, Section Virus-Host-Interactions, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany., Traut J; Department of Infectious Diseases, Molecular Virology, Section Virus-Host-Interactions, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany., Piras A; Institute of Virology, School of Medicine, Technical University of Munich, Munich, Germany., Acosta-Rivero N; Department of Infectious Diseases, Molecular Virology, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany., Gonçalves Magalhães V; Division of Virus-Associated Carcinogenesis, German Cancer Research Center (DKFZ), Heidelberg, Germany., Springer E; Institute of Molecular Immunology, University Hospital Klinikum rechts der Isar, Technical University of Munich, Munich, Germany., Betz A; Department of Infectious Diseases, Molecular Virology, Section Virus-Host-Interactions, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany., Huang HE; Department of Infectious Diseases, Molecular Virology, Section Virus-Host-Interactions, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany., Park J; Bioinformatics and Omics Data Analysis, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.; School of Biomedical Convergence Engineering, Pusan National University, Yangsan, Republic of Korea., Qiu R; Heidelberg University, Medical Faculty, Department of Pediatric Oncology, Hematology, Immunology and Pneumology, Heidelberg, Germany., Gnouamozi GE; Department of Infectious Diseases, Molecular Virology, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany., Mehnert AK; Department of Infectious Diseases, Virology, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany., Dao Thi VL; Department of Infectious Diseases, Virology, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; German Center for Infection Research (DZIF), Heidelberg Partner Site, Heidelberg, Germany., Urban S; Department of Infectious Diseases, Molecular Virology, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; German Center for Infection Research (DZIF), Heidelberg Partner Site, Heidelberg, Germany., Muckenthaler M; Heidelberg University, Medical Faculty, Department of Pediatric Oncology, Hematology, Immunology and Pneumology, Heidelberg, Germany., Schlesner M; Bioinformatics and Omics Data Analysis, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Biomedical Informatics, Data Mining and Data Analytics, Faculty of Applied Computer Science and Medical Faculty, University of Augsburg, Augsburg, Germany., Wohlleber D; Institute of Molecular Immunology, University Hospital Klinikum rechts der Isar, Technical University of Munich, Munich, Germany., Binder M; Division of Virus-Associated Carcinogenesis, German Cancer Research Center (DKFZ), Heidelberg, Germany., Bartenschlager R; Department of Infectious Diseases, Molecular Virology, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; Division of Virus-Associated Carcinogenesis, German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Center for Infection Research (DZIF), Heidelberg Partner Site, Heidelberg, Germany., Pichlmair A; Institute of Virology, School of Medicine, Technical University of Munich, Munich, Germany.; German Center for Infection Research (DZIF), Munich Partner Site, Munich, Germany., Lohmann V; Department of Infectious Diseases, Molecular Virology, Section Virus-Host-Interactions, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; German Center for Infection Research (DZIF), Heidelberg Partner Site, Heidelberg, Germany.
Source: Frontiers in immunology [Front Immunol] 2025 Apr 22; Vol. 16, pp. 1568056. Date of Electronic Publication: 2025 Apr 22 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1664-3224
DOI:10.3389/fimmu.2025.1568056